Cedric Francois - Sep 1, 2023 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/ David Watson, attorney-in-fact for Cedric Francois
Stock symbol
APLS
Transactions as of
Sep 1, 2023
Transactions value $
-$5,461,959
Form type
4
Date filed
9/1/2023, 04:05 PM
Previous filing
May 25, 2023
Next filing
Sep 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $801K +300K +109.23% $2.67* 575K Sep 1, 2023 Direct
transaction APLS Common Stock Sale -$5.83M -140K -24.31% $41.70 435K Sep 1, 2023 Direct F5
transaction APLS Common Stock Sale -$436K -10.3K -2.36% $42.44 425K Sep 1, 2023 Direct F6
holding APLS Common Stock 383K Sep 1, 2023 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023 - 2) F1
holding APLS Common Stock 654K Sep 1, 2023 Indirect Owner (The Cedric Francois Irrevocable Trust of 2023) F2
holding APLS Common Stock 300K Sep 1, 2023 Indirect Owner (The Francois Grossi Trust) F3
holding APLS Common Stock 234K Sep 1, 2023 Indirect Owner (The Francois-DuBois Educational Trust) F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (Right to Buy) Options Exercise $0 -300K -100% $0.00* 0 Sep 1, 2023 Common Stock 300K $2.67 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The securities are held by The Cedric Francois Irrevocable Trust of 2023 - 2. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023 - 2. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 - 2 except to the extent of his pecuniary interest therein.
F2 The securities are held by The Cedric Francois Irrevocable Trust of 2023. William V. A. Zorn is the trustee of The Cedric Francois Irrevocable Trust of 2023. The reporting person disclaims beneficial ownership over the shares held by The Cedric Francois Irrevocable Trust of 2023 except to the extent of his pecuniary interest therein.
F3 The securities are held by The Francois Grossi Trust, for which Juliana Grossi, the spouse of the reporting person, serves as trustee. The reporting person disclaims beneficial ownership over the shares held by the Francois Grossi Trust except to the extent of his pecuniary interest therein.
F4 The securities are held by The Francois-DuBois Educational Trust, for which the Fiduciary Trust Company of New England serves as trustee. The reporting person disclaims beneficial ownership over the shares held by The Francois-DuBois Educational Trust except to the extent of his pecuniary interest therein.
F5 This transaction was executed in multiple trades at prices ranging from $41.26 - $42.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F6 This transaction was executed in multiple trades at prices ranging from $42.27 - $42.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F7 This option was granted on December 5, 2013 and fully vested.